New Nordic Healthbrands (NNH) Q2 2026 earnings summary

Executive summary

• Net sales for Q2 2026 rose 14.5% year-over-year to SEK 163.8 million, with organic growth of 16.3%.

• Q2 marked record revenue, driven by strong distributor performance in Asia, and solid growth in the Nordics and US.

• New product launches under Hair Volume™, Magic Magnesium™, and Longevity lines contributed to sales growth.

• Retailers in several countries are reducing inventories amid liquidity challenges, but direct-to-consumer initiatives are underway.

Financial highlights

• Q2 gross margin declined to 63.5% (from 64.8%), but gross profit increased to SEK 104.1 million.

• Operating profit (EBIT) for Q2 improved to SEK 9.0 million (from SEK 3.8 million); net profit rose to SEK 7.3 million (from SEK 2.1 million).

• For H1 2026, net sales increased 3.3% to SEK 296.2 million; net profit was SEK 4.4 million (down from SEK 4.8 million).

• Cash flow from operating activities in Q2 was SEK 5.3 million; H1 cash flow from operations was negative SEK 5.7 million.

Outlook and guidance

• Management expects improved performance in Europe and Canada in H2 2026, with continued focus on organic growth and operational efficiency.

• New distribution partnerships in South Korea and Mexico are anticipated in H2 2026.

• Commercial sales of New Nordic Extracts are expected to contribute positively to earnings from 2027.